Neonatologia
La fototerapia ciclica
Cyclic phototherapy in the promotion of mother-infant zero separation and breastfeeding in tailored neonatal treatments
Riccardo Davanzo1, Paola Cavicchioli2, Massimo Agosti31, Carlo Dani4
1Centro di Ricerca in Nutrizione, Università dell’Insubria, Varese; Commissione Allattamento e BLUD
della Società Italiana di Neonatologia (Com.A.SIN), Trieste
2UO di Pediatria e Neonatologia, Ospedale dell’Angelo, Mestre
3Dipartimento di Pediatria, Ospedale Del Ponte, Università dell’Insubria, Varese
4SOD di Neonatologia e Terapia Intensiva Neonatale, Azienda Ospedaliero Universitaria Careggi, Firenze
Febbraio 2025 - pagg. 103 -106 | DOI: 10.53126/MEB44103
Abstract
A proactive approach to the management of hyperbilirubinemia during phototherapy may help reduce mother-infant separation, maintain comfort of the newborn, reduce maternal anxiety and promote exclusive breastfeeding. Cyclic phototherapy may be part of such an approach, as it has been documented equally effective to continuous phototherapy for the treatment of neonatal jaundice, while possibly reducing the proven adverse effects of phototherapy.
Riassunto
Un approccio proattivo alla gestione dell’iperbilirubinemia durante la fototerapia può aiutare a ridurre la separazione madre-bambino, mantenere il comfort del neonato, ridurre l’ansia materna e promuovere l’allattamento al seno esclusivo. La fototerapia ciclica può far parte di tale approccio, poiché è stata documentata la stessa efficacia della fototerapia continua per il trattamento dell’ittero neonatale, riducendo possibilmente gli effetti avversi comprovati della fototerapia.
Parole chiave
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Bergman NJ. Birth practices: Maternal-neonate separation as a source of toxic stress. Birth Defects Res 2019;111(15):1087-109. doi: 10.1002/bdr2.1530.
2. van Veenendaal NR, van Kempen AAMW, Broekman BFP, et al. Association of a Zero-Separation Neonatal Care Model With Stress in Mothers of Preterm Infants. JAMA Netw Open 2022;5(3):e224514. doi: 10.1001/jamanetworkopen.2022.4514.
3. Kemper AR, Newman TB, Slaughter JL, et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics 2022;150(3):e2022058859. doi: 10.1542/peds.2022-058859.
4. Sarathy L, Chou JH, Romano-Clarke G, Darci KA, Lerou PH. Bilirubin Measurement and Phototherapy Use After the AAP 2022 Newborn Hyperbilirubinemia Guideline. Pediatrics 2024;153(4):e2023063323. doi: 10.1542/peds.2023-063323.
5. Michienzi MR, Tomasini DK, Fisher CC, Ponnapakkam AP. Implementation of the Revised American Academy of Pediatrics Clinical Practice Guidelines for Hyperbilirubinemia Decreases Necessity for Serum Bilirubin and Phototherapy. Jt Comm J Qual Patient Saf 2025;51(2):95-100. doi: 10.1016/j.jcjq. 2024.10.013.
6. Bhutani VK, Wong RJ, Turkewitz D, Rauch DA, Mowitz ME, Barfield WD; COMMITTEE ON FETUS & NEWBORN. Phototherapy to Prevent Severe Neonatal Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation: Technical Report. Pediatrics 2024;154(3):e2024068026. doi: 10.1542/ peds.2024-068026.
7.Ebbesen F, Vreman HJ, Hansen TWR. Blue-Green (~480 nm) versus Blue (~460 nm) Light for Newborn Phototherapy-Safety Considerations. Int J Mol Sci 2022;24(1):461. doi: 10.3390/ijms24010461.
8. Lau SP, Fung KP. Serum bilirubin kinetics in intermittent phototherapy of physiological jaundice. Arch Dis Child 1984;59(9):892-4. doi: 10.1136/adc.59.9.892.
9. Arnold C, Tyson JE, Pedroza C, et al. Cycled Phototherapy Dose-Finding Study for Extremely Low-Birth-Weight Infants: A Randomized Clinical Trial. JAMA Pediatr 2020;174(7):649-656. doi: 10.1001/jamapediatrics.2020.0559. Erratum in: JAMA Pediatr 2020;174(7):732. doi: 10.1001/jamapediatrics. 2020.1863.
10. Dani C, Remaschi G, Rossi F, et al. Splanchnic and cerebral oxygenation during cyclic phototherapy in preterm infants with hyperbilirubinemia. Eur J Pediatr 2024;183(12): 5313-9. doi: 10.1007/s00431-024-05810-1.
11. Demirel HN, Ozumut SS, Ovalı HF. Continuous versus intermittent phototherapy in treatment of neonatal jaundice: a randomized controlled trial. Eur J Pediatr 2024;183(8): 3389-96. doi: 10.1007/s00431-024-05610-7.
12. Romagnoli C, Dani C, Pratesi S, Raimondi F, Capasso L, Zecca E. Task Force per l’Iperbilirubinemia Neonatale. Raccomandazioni per il trattamento dell’iperbilirubinemia neonatale. Società Italiana di Neonatologia, 2013.
13. Flaherman VJ, Maisels MJ; Academy of Breastfeeding Medicine. ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation-Revised 2017. Breastfeed Med 2017;12(5):250-7. doi: 10.1089/bfm. 2017.29042.vjf.
14. Gottimukkala SB, Lobo L, Gautham KS, Bolisetty S, Fiander M, Schindler T. Intermittent phototherapy versus continuous phototherapy for neonatal jaundice. Cochrane Database Syst Rev 2023;3(3):CD008168. doi: 10.1002/14651858.CD008168.pub2.
15. Davanzo R, Salvatori G, Baldassarre M, Cetin I, Viora E, Scarpato E; “HPB Project” Working Group. Promotion of breastfeeding in Italian Maternity Hospitals: a pre-intervention study. Ital J Pediatr 2024;50(1):219. doi: 10.1186/s13052-024-01793-9.
Corrispondenza: riccardo.davanzo@gmail.com